Hans Bohn

This inventor holds 25 USPTO granted patents, primarily in Protein Isolation Techniques. Top assignees: Behringwerke Aktiengesellschaft, Hoechst Aktiengesellschaft. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Bohn. Retrieved from https://idiyas.com/inventor/hans-bohn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25

% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 10

Forward Citations = 281(Granted Patents)

Location History:

Marbach, near Marburg an der Lahn, DE (1976)
Marbach near Marburg an der Lahn, DE (1976 - 1977)
Marburg, Marbach, DE (1977)
Marburg an der Lahn, DE (1980 - 1984)
Marburg, DE (1980 - 1988)

Company Filing History:

24 out of 340

Behringwerke Aktiengesellschaft

patents

1 out of 6,705

Hoechst Aktiengesellschaft

patents

Years Active: 1976-1988

Loading Chart...

Areas of Expertise:

Tissue Protein

Glycoprotein

Protein Isolation

Placenta-Specific Protein

Contraceptive Agent

Steroid-Binding Globulin

Fibrin-Stabilizing Factor

Membrane-Associated Proteins

Enrichment Process

Protein Preparation

Human Placental Tissues

Ubiquitary Protein

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4746731 - Isolated tissue protein PP.sub.18 (1988-05-24),

2. 4599318 - Tissue protein PP.sub.19, a process for obtaining it, and its use (1986-07-08),

3. 4594328 - Tissue protein PP.sub.21, a process for obtaining it and its use (1986-06-10),

4. 4592863 - Protein PP.sub.20, a process for obtaining it, and its use (1986-06-03),

5. 4524027 - Membrane-associated proteins (MP.sub.2), a process for obtaining them, (1985-06-18),

6. 4507229 - Tissue protein PP.sub.4, a process for isolating it and its use (1985-03-26),

7. 4500451 - New protein PP.sub.13 extracted from human placental tissues and use (1985-02-19),

8. 4468345 - Protein (PP.sub.17), a process for concentrating and isolating it and (1984-08-28),

9. 4402872 - Protein and process for isolating it (1983-09-06),

10. 4368148 - Protein PP.sub.9, process for its enrichment and its isolation and its (1983-01-11),

11. 4348316 - New protein PP.sub.15, a process for its preparation and its use (1982-09-07),

12. 4325866 - Protein, PP.sub.11, a process for its preparation and its use (1982-04-20),

13. 4302385 - Placenta-specific tissue protein PP.sub.10 (1981-11-24),

14. 4301064 - Ubiquitary tissue protein PP.sub.8 (1981-11-17),

15. 4297343 - Contraceptive agent (1981-10-27),

Title: The Innovative Mind of Hans Bohn

Introduction

Hans Bohn, a notable inventor based in Marburg, Germany, has made significant contributions to the field of biotechnology. With an impressive portfolio of 25 patents, Bohn's work primarily revolves around the isolation and application of essential proteins. His innovative spirit and dedication to research have earned him a respected place among his peers.

Latest Patents

Among Hans Bohn's latest innovations is his patent concerning the isolated tissue protein PP.sub.18. This protein exhibits distinct characteristics as well as another related protein, PP.sub.19. His work not only outlines the process of obtaining these proteins but also their potential applications across various industries.

Career Highlights

Bohn has had a distinguished career, contributing his expertise to leading pharmaceutical companies such as Behringwerke Aktiengesellschaft and Hoechst Aktiengesellschaft. His tenure at these organizations allowed him to pursue groundbreaking research and foster advancements in biotechnology.

Collaborations

Throughout his career, Hans Bohn collaborated with esteemed colleagues including Wilhelm Winckler and Ferdinand Stutzinger. Their collective efforts have driven forward innovations that continue to shape the landscape of protein research and application.

Conclusion

In summary, Hans Bohn's contributions to the field of biotechnology are marked by his extensive patent portfolio and his commitment to innovation. His collaborations and work within prominent companies have set a standard for future research endeavors, ensuring that his legacy will endure in the annals of scientific advancement.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]